MedTrace Logo

Desensitization for Highly Sensitized Recipients of Pancreas Transplantation

NCT00867386 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2014-03-13

No results posted yet for this study

Summary

This is an observational study for patients with type 1 diabetes, whom are already scheduled to have desensitization treatment to help increase the chance of receiving a pancreas transplant.The study staff will be looking at medical records in order to collect past, present and future information for each subject's medical condition and/or transplant. There are no additional study tests, procedures or devices needed for our analysis.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Xunrong Luo, MD, PhD · Northwestern University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2013-07-31
Completion
2013-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00867386 on ClinicalTrials.gov